Retrospective analysis of patients (pts) with metastatic melanoma (MM) showing long-term response (LTR) to vemurafenib (Vb).

被引：0
|
作者：
Galli, Giulia
Di Guardo, Lorenza
Cimminiello, Carolina
Cavalieri, Stefano
Rodolfo, Monica
Rivoltini, Licia
Valeri, Barbara
Bono, Aldo
Tolomio, Elena
Del Vecchio, Michele
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e21001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21001
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Long-Term Survival in Patients with Metastatic Melanoma Treated with DTIC or Temozolomide
    Kim, Christina
    Lee, Christopher W.
    Kovacic, Laurel
    Shah, Amil
    Klasa, Richard
    Savage, Kerry J.
    ONCOLOGIST, 2010, 15 (07): : 765 - 771
  • [22] Predictors of long-term survival in stage IV malignant melanoma (MM) patients
    Bafaloukos, D
    Fountzilas, G
    Semoglou, C
    Vasilaki, V
    Kosmidis, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1166 - 1166
  • [23] Long-term survival of patients (pts) with advanced melanoma treated with ipilimumab with or without dacarbazine
    Hersh, E.
    Weber, J.
    Powderly, J.
    Pavlik, A.
    Nichol, G.
    Yellin, M.
    Cranmer, L.
    Urba, W.
    O'Day, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Long-term survival with modern therapeutic agents against metastatic melanoma-vemurafenib and ipilimumab in a daily life setting
    Lang, B. M.
    Peveling-Oberhag, A.
    Faidt, D.
    Hoetker, A. M.
    Weyer-Elberich, V.
    Grabbe, S.
    Loquai, C.
    MEDICAL ONCOLOGY, 2018, 35 (03)
  • [25] Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib plus Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
    Piejko, Karolina
    Cybulska-Stopa, Bozena
    Zietek, Marcin
    Dziura, Robert
    Galus, Lukasz
    Kempa-Kaminska, Natasza
    Ziolkowska, Barbara
    Rutkowska, Ewa
    Kopcinski, Tomasz
    Kubiatowski, Tomasz
    Bal, Wieslaw
    Suwinski, Rafal
    Mackiewicz, Jacek
    Kaminska-Winciorek, Grazyna
    Czarnecka, Anna M.
    Rutkowski, Piotr
    TARGETED ONCOLOGY, 2023, 18 (02) : 235 - 245
  • [26] Factors associated with the prognosis and long-term survival of patients with metastatic lung adenocarcinoma: a retrospective analysis
    Huang, Chen-Yang
    Chen, Bo-Huan
    Chou, Wen-Chi
    Yang, Cheng-Ta
    Chang, John Wen-Cheng
    JOURNAL OF THORACIC DISEASE, 2018, 10 (04) : 2070 - 2078
  • [27] A RETROSPECTIVE ANALYSIS OF LONG-TERM SURVIVORS WITH METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
    Hayashi, H.
    Kondo, S.
    Shiba, S.
    Sakamoto, Y.
    Morizane, C.
    Ueno, H.
    Okusaka, T.
    ANNALS OF ONCOLOGY, 2013, 24
  • [28] Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma
    Bedikian, Agop Y.
    Johnson, Marcella M.
    Warneke, Carla L.
    Papadopoulos, Nicholas E.
    Kim, Kevin
    Hwu, Wen-Jen
    Mclntyre, Susan
    Hwu, Patrick
    CANCER INVESTIGATION, 2008, 26 (06) : 624 - 633
  • [29] The survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors
    Lai-Kwon, J. E.
    Khoo, C.
    Lo, S.
    Milne, D.
    Mohamed, M.
    Raleigh, J.
    Smith, K.
    Lisy, K.
    Sandhu, S. K.
    Jefford, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [30] The Brazilian experience with biochemotherapy for metastatic melanoma: Long-term results in 163 patients
    Moreira, Raphael Brandao
    D'Alpino, Renata D'Alpino
    Soares de Sousa, Tercia Tarciane
    Lino, Aline Da Rocha
    Gomes, Jessica Ribeiro
    Fernandes Amarante, Marcus Paulo
    Haddad, Carolina Kawamura
    Schmerling, Rafael
    Maluf, Fernando C.
    Buzaid, Antonio C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345